Evaluation of iron chelator administration, and cochlear implantation for s uperficial siderosis (ECHACISS)

Evaluation of iron chelator administration, and cochlear implantation for s uperficial siderosis (ECHACISS) - Evaluation of iron chelator administration, and cochlear implantation for s uperficial siderosis (ECHACISS)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021218

Enrollment

Registered

2016-02-26

Start date

2024-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial siderosis of CNS

Interventions

deferiprone administration cochlear implantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients diagnosed as having superficial siderosis of the CNS

Exclusion criteria

Exclusion criteria: anaphylaxis to iron chelator patients receiving any drug having side effect of leukopenia pregnant person claustrophobia inadequate patients

Design outcomes

Primary

Measure	Time frame
hearing ability, cerebellar ataxia (SARA, ICARS), MRI findings, pyramidal sign, electrophysiological studies, central conduction time	—

Secondary

Measure	Time frame
persistence rate of treatment, CSF findings, safety	—

Countries

Japan

Contacts

Public Contactsame same

same same

n-sanjo.nuro@tmd.ac.jp03-5803-5234

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026